FreeAgent c6042a01e5b083aaa0508808faa25357ea849a1f false No description of principal activity 09 October 2024 31 October 2025 160067312024-10-092025-10-31 16006731uk-bus:Director12024-10-092025-10-31 16006731uk-bus:AuditExempt-NoAccountantsReport2024-10-092025-10-31 16006731uk-bus:Micro-entities2024-10-092025-10-31 16006731uk-bus:FullAccounts2024-10-092025-10-31 16006731uk-bus:PrivateLimitedCompanyLtd2024-10-092025-10-31 16006731uk-bus:RegisteredOfficeuk-countries:UnitedKingdom2024-10-092025-10-31 160067312024-10-09 160067312025-10-31 16006731uk-core:CurrentFinancialInstruments2025-10-31 16006731uk-core:Non-currentFinancialInstruments2025-10-31 iso4217:GBP xbrli:pure

Sergene Biosciences Ltd

Unaudited financial statements for the period from 09 October 2024 to 31 October 2025


Company information

Sergene Biosciences Ltd is a private company limited by shares, registered in England and Wales, registered number 16006731.

The company's registered office is: 26 Woodward Close, Winnersh, Wokingham, RG41 5NW, United Kingdom.

Balance Sheet

as at 31 October 2025

13 months to
31 Oct 25
£ £
Current assets 2,932.45
Creditors: amounts falling due within one year (1,155.20)
Net current assets / (liabilities) 1,777.25
Total assets less current liabilities 1,777.25
Accruals and deferred income (380.00)
Net assets 1,397.25
Capital and reserves 1,397.25

For the period from 09 October 2024 to 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Directors' responsibilities:

Approved by the board of directors and signed on behalf of the board,

Dr. Spyridon Servos
07 July 2026

Notes to the accounts

  1. Average number of employees

    During the period the average number of employees was 0.